- Acute Aortic Syndrome consists of
-
- Aortic dissection (commonest)
- Intramural haematoma
- Penetrating aortic ulcer
- Aortic pseudo-aneurysm
- Traumatic or iatrogenic aortic injury
-
- Aortic atheroma
-
- Thickened intima, atheroma, sometimes mobile or ulcerated components
- If severe (atheroma >4mm) or complex (mobile or ulcerated components) – much higher risk of CVA. Treat with statins and single anti-platelet
-
- Primary types of aortic aneurysm
-
- Abdominal
- Thoracic
-
Dilated thoracic aorta / thoracic aortic aneurysms (TAA)
- Usually diagnosed incidentally
- The aorta enlarges with age (by around 0.8mm/decade, and faster in women than men).
- Aneurysms more common in men (as is dissection) but degenerative TAAs grow faster in women and have a higher risk of dissection
- Definitions
-
- Body surface area, or height, is commonly used to normalise aortic dimensions
- Ascending thoracic aortic dilatation defined as >22 mm/m2
- Normograms or z scores compare measured to expected aortic diameter, however in practice, aortic root dilatation is suspected when aorta is >40mm in men and >36mm in women (Annual risk of dissection is around 4% once TAA is 57mm)
- An aneurysm is defined as >1.5 x larger than predicted size, but ‘significant aortic dilatation’ is a term more commonly used
- Saccular aneurysm – due to infection, penetrating atherosclerotic ulcer, trauma or inflammation. Higher risk
- Fusiform aneurysm – usually due to a CTD
-
- Risk factors
-
- HTN (80%)
- Genetics (20%)
- Found in 25% of patients with bicuspid aortic valve
-
- Causes of TAA
-
- Root/ascending aorta/arch (70%) – Genetic causes, bicuspid aortic valve, sporadic, atherosclerosis
- Descending aorta (30%) – atherosclerosis (most), aortitis (infectious or not), trauma, coarctation
- TAAs can extend into the abdominal aorta: thoracoabdominal aortic aneurysm (of which there are 5 subtypes, with different risks)
-
- Causes of aortitis
-
- Large vessel vasculitis – GCA, Takayasu’s
- Other rheumatological conditions – SLE, RA, Sarcoid, Behcet’s, Cogan’s syndrome, ANCA-associated vasculitides, HLA-B27 associated spondyloarthropathies, relapsing polychondritis
- Infections – TB/mycobacteria, syphilis, salmonella, Q fever and brucellosis, staph and strep
- Other – Idiopathic, peri-aneurysmal aortitis, retroperitoneal fibrosis
-
- Risks for rupture
-
- Underlying CTD/genetic cause
- Diameter >50mm (and especially if >60mm) or fast rate of growth
- HTN
- Smoking and COPD
- Symptoms
- Chronic dissection
- Old age
-
- Investigation
-
- Echo to screen for TAA
- If diagnosed by echo, do an ECG-triggered cardiac CT or MRI (this will confirm max diameter, rule out isolated single sinus dilatation and provide a baseline)
- Assess entire aorta if TAA diagnosed, and assess aortic valve
-
- Management
-
- Patients should be given standard CV risk reduction lifestyle advice, and also advised to limit isometric exercise
- Treat HTN (target 120/80 if tolerated)
- Metformin might reduce rate of growth in diabetics
- Statin (unless low CV risk and non-atherosclerotic TAA)
- Consider single antiplatelet
- Some advice avoiding fluroquinolone antibiotics which may increase risk of rupture/progression
- Consider surgery
-
- Surgery generally advised if ascending aorta/root >50mm (or descending thoracic aneurysm of >55mm, or thoracoabdominal aortic aneurysm >60mm)
-
- Stronger indications (lower threshold) for surgery include bicuspid valve, ascending aorta >55mm, young age, uncontrolled HTN, family hx of dissection, lower operative risks, patient also requires aortic valve replacement, high growth rate (>3mm/year), aortic length >11mm, coarctation, planning pregnancy
- Type of surgery depends on location of aneurysm and other factors (TEVAR best for descending aneurysms if no CTD)
- Endoleaks (5 types) can develop after TEVAR and EVAR – some require re-intervention especially in types 1 and 3. Always do a CT within first month post-op
- Other complications include pseudo-aneurysms and graft infections
-
- Surveillance
-
- Echo or CT if aortic root/ascending aorta, CT for arch/distal thoracic aorta.
- Can use echo for follow up but only if agreement between echo and CT (if >3mm difference, use CT)
- Use same imaging to compare over time
- CMR can also be used but less availability
- If root/ascending aorta 40-44mm – echo annually, and then every 2-3 years if growth <3mm/year
- If root/ascending aorta 45-49mm – annual echo
- If root/ascending aorta >50mm and no intervention advised – echo every 6 months
- If growth rate >3mm/year – echo every 6 months
-
- Prognosis – untreated descending thoracic aneurysm has 54% 5-year survival
Intramural haematoma
- Haemorrhage within aortic media (+/- intimal disruption)
- 65% involve descending aorta
- Occurs at an older age than dissection on average but risk factors similar
- Symptoms also similar, but less risk of AR, malperfusion, and pulse deficit
- CT shows crescentic or circular aortic wall thickening in the absence of an intimal flap or aortic wall enhancement
- Can evolve into dissection (12%), and aneurysms
- Regression occurs in over 30%
- High mortality
- Managed similarly to dissection – medical treatment, surgery for type A, consider TEVAR for type B (especially if complicated or high-risk factures)
Penetrating atherosclerotic ulcer (PAU)
- Often multiple present, most commonly in the descending aorta
- Mostly affects older male multimorbid smokers
- Often incidental finding (symptoms may suggest ulcer expansion)
- If symptoms – similar medical treatment as for dissection (eg analgesia, HR and BP control etc)
- Surgery advised for type-A PAU (these are rare, but high risk of rupture)
- For type-B PAU: Endovasular intervention often advised if haemodynamically unstable, contained/impending rupture, refractory pain, aorta >55mm, large pseudoaneurysm, intramural haematoma or high-risk imaging features
- If chronic / asymptomatic penetrating ulcer – medical treatment, surveillance, and consider intervention if significant growth of ulcer/aorta >55mm/high risk imaging features
Aortic pseudo-aneurysm
-
- Can be due to trauma, surgery or infection
- Often symptomless
- Can lead to rupture – so usually repaired regardless of size or position
Mycotic aortic aneurysms
- Infected aneurysms – generally bacterial, despite the name (usually staph or salmonella, occasionally anaerobes or TB). Called mycotic because mushroom-shaped, not because they have a fungal aetiology (although very rarely they do)
- Can be due to
-
- Contiguous infection extending into the aorta (eg from vertebral osteomyelitis, intraabdominal infections/abscesses, pancreatitis)
- Septic emboli eg IE (30%, this is the most common cause)
- Infected pseudoaneurysms eg post trauma or drug injection
-
- Can arise form pre-existing aortic aneurysms or from healthy aorta
- Most commonly affects abdominal aorta, intracranial arteries, peripheral arteries and visceral arteries, in that order
- Most patients symptomatic at time of diagnosis
- Imaging can help differentiate inflamed aorta (aortitis) from infected aorta (mycotic AA)
Abdominal aortic aneurysms (AAA)
- Can be suprarenal, pararenal, juxtarenal or infrarenal
- Generally an AAA is >30mm (and mean growth is 3mm/year)
- Risk of rupture rises exponentially depending on diameter
- Asymptomatic in 65%
- Often found incidentally
- The 10-year CV event mortality risk is 15 times higher than risk of rupture
- Causes
-
- Atherosclerosis
- Media degeneration
- Genetic disorders
- Infection or inflammation (10%)
-
- Risk factors
-
- Europeans
- Men (but 4x more likely to rupture in women)
- Smokers
- Family hx (relative risk about 2)
- HTN is the most important risk factor (DM actually protects)
- Old age
-
- Women with a ruptured AAA are almost always aged >75, and either smokers or hypertensive (or both)
- AAA growth is unpredictable (especially at larger sizes)
- 25% of patients with AAA also have a thoracic aortic aneurysm, and in 25% of AAA it extends down to common iliacs
- Screening
-
- Duplex US best (but do CT if evaluating for repair)
- Men can self-refer as at higher risk
- Indicated for men aged 66 and over, and consider for women aged 70 and over, if they have any of:
-
- COPD
- Vascular disease – IHD, PVD, PAD, cerebrovascular disease
- Family hx of AAA
- Hyperlipidaemia, HTN, past/current smoker
-
-
- Management
-
- If AAA >5.5cm – refer to vascular, ideally reviewed in 2 weeks
- If AAA >3cm – refer to vascular, ideally reviewed in 12 weeks
- Consider family screening
- CV risk reduction
- Discuss risk of rupture vs risks of surgery (and explain that AAA growth can be a bit unpredictable)
- Medical treatment – same as for TAA above
- Consider planned surgical intervention once AAA >50mm in women and >55mm in men
-
- Surveillance US
-
- Required if no imminent surgery or if repaired via EVAR
- If AAA >25mm scan every 4 years
- If 30-39mm scan every 3 years
- If 40-44mm scan every year
- If >45mm scan every 6 months in women and every year in men
- If >50mm in men scan every 6 months
- Consider shorter intervals if rapid growth (eg >5mm in 6 months or >10mm in a year)
-
- Radiological signs of AAA rupture
-
- Retroperitoneal haematoma
- High crescent sign
- Tangential calcification
- Thrombus fissuration
- Contrast extravasation
- Paraortic fat stranding
- Calcification discontinuity
- Draped aorta sign
-
- If rupture / imminent rupture
-
- Consider urgent transfer (within 30 mins) to regional vascular centre
- Restrictive volume resus
- EVAR usually best if female or men aged > 70, open repair more often done for men aged < 70.
- Intraabdominal compartment syndrome can occur after repair or EVAR
-
- Elective repair
-
- Considered if symptomatic, if >40mm and has grown > 10mm/year, if >55mm in men or if >50mm in women
- Life expectancy must be > 2 years
- Consider exercise testing pre-op
- Do not use risk assessment tools for individual patients when considering surgery
- Usually open repair, occasionally EVAR (if abdominal co-pathology, or high operative risk)
- CAD is leading cause of early death after AAA repair
- Will need surveillance imaging afterwards (for endoleaks)
-